U.S. Markets open in 10 hrs, 45 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,715.18 | 212.67 | 1.85% |
| NASDAQ | 2,411.64 | 29.18 | 1.22% |
| S&P 500 | 1,300.68 | 19.02 | 1.48% |
| Day Low 09:30 AM EDT | 14.165 | |
|---|---|---|
| Day High 02:34 PM EDT | 14.91 |
|
| Range | 0.75 | |
| Volume | 262,122 | |
| 30-Day Avg. Vol. | 522,000 |
|
| Difference | -49.79% | |
| Market Cap. | 537.3 M | |
| Change | 12.88 M | |
| Shares Out. | 36.82 M | |
| Percent Traded | 0.71% | |
| Revenue | 21.56 M | |
| Earnings | -68.88 M | |
| EPS (TTM) | -1.72 |
| 52-Wk Low 11/10/07 | 4.58 | |
|---|---|---|
| 52-Wk High 8/6/08 | 20.00 |
|
| Range | 15.42 | |
| Prev. Close 8/27/08 | 14.24 | |
| Today's Open | 14.45 | |
| Change | 1.47% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 1.8709 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -8.00 |
Momenta Pharmaceuticals looks to increase momentum for its drug candidates. The biotech company specializes in engineering complex sugars to improve versions of existing drugs, as well as to discover more-effective ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.51 3/31/08 | -0.37 3/31/08 |
0.14
Beat
|
| Last Quarter | -0.443 6/30/08 | -0.42 6/30/08 |
0.023
Beat
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 3.56 M | 21.56 M |
| Gross Profit | -9.78 M | -48.34 M |
| Operating Income | -15.70 M | -76.56 M |
| Net Income | -14.97 M | -68.88 M |
Real-Time Quote
